HIND: Utang jangka cendhak perusahaan Vyome Holdings Inc

The price chart for Vyome Holdings Inc (HIND) reflects the dynamics of a biopharmaceutical business developing unique treatments for fungal skin lesions. The current figure for separate short-term debt stands at 0.00. The company is losing market share in the bandaging segment due to the expansion of injectable weight-loss drugs. Growth prospects rely on combating antibiotic resistance through new anti-inflammatory developments.

HIND (Vyome Holdings Inc.) riwayat Utang jangka cendhak perusahaan saka 16.08.2025 nganti 01.11.2026

This indicator measures the aggregate of all financial obligations of Vyome Holdings Inc (HIND) due within twelve months, allowing for an assessment of the risk of a liquidity gap. By analyzing the volume of short-term debt capital, an investor determines management's ability to fund the development of various antimicrobial therapies, where liquidity control is critical to ensuring the stability of a diversified clinical trial portfolio.

Analisis pesaing

ARGX - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan BNTX (BioNTech Inc.)|Abivax (ABVX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ADMA Corp|PTGX (Protagonist Therapeutics) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan immunovant.com|Kewajiban jangka cendhak perusahaan KNSA (Kiniksa)|GRFS (Grifols SA) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ADPT (Adaptive Biotechnologies Corp)|Gunggunge utang jangka cendhak Celldex Corp (CLDX)|AUPH - Utang jangka cendhak perusahaan|biocryst.com (BCRX) - Kewajiban jangka cendhak perusahaan|Vera Therapeutics (VERA) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Dianthus Therapeutics Inc|Kewajiban jangka cendhak perusahaan PHVS|Utang jangka cendhak perusahaan abcellera.com|Utang jangka cendhak perusahaan Tourmaline Bio, Inc. (TRML)|precigen.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Utang jangka cendhak|UPB: Kewajiban jangka cendhak perusahaan|ZBIO: Utang jangka cendhak perusahaan|IMNM (Immunome, Inc.) - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak gossamerbio.com (GOSS)|Utang jangka cendhak perusahaan KalVista Pharmaceuticals, Inc.|Utang jangka cendhak Septerna, Inc. SEPN|Utang jangka cendhak perusahaan Pieris Pharmaceuticals Inc (PVLA)|Kewajiban jangka cendhak perusahaan Savara Pharma SVRA|Utang jangka cendhak perusahaan RIGL (Rigel Pharmaceuticals)|anaptysbio.com (ANAB) - Utang jangka cendhak|ATXS: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan ENGN (enGene Holdings Inc)|RAPT: Utang jangka cendhak perusahaan|Aerovate Therapeutics - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Aclaris Therapeutics|Utang jangka cendhak kyvernatx.com KYTX|Utang jangka cendhak perusahaan Tiziana Life Sciences Ltd (TLSA)|Utang jangka cendhak perusahaan CABA (Cabaletta Bio Inc.)|Utang jangka cendhak perusahaan VTYX (Ventyx Bio)|THTX: Tanggungan utang jangka cendhak perusahaan|Avalo Therapeutics, Inc - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak eledon.com ELDN|Agenus Inc. (AGEN) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan CLYM|ZURA (Zura Bio) - Utang jangka cendhak perusahaan|ATYR - Tanggungan jangka cendhak|Utang jangka cendhak perusahaan Adagene (ADAG)|Gunggunge utang jangka cendhak ikenaoncology.com|Shattuck Labs - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan EQ|Connect Pharma - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Immunic, Inc. IMUX|atarabio.com (ATRA) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan IFRX|XFOR (X4 Pharmaceuticals, Inc.) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Adicet (ACET)|Utang jangka cendhak perusahaan CELU|INMB (INmune Bio Corporation) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan BRNS (Barinthus Biotherapeutics)|Gunggunge utang jangka cendhak kezarlifesciences.com (KZR)|SABS - Utang jangka cendhak perusahaan|AKTX (Akari Therapeutics PLC) - Tanggungan utang jangka cendhak perusahaan|ENLV: Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan QTTB|Utang jangka cendhak perusahaan GeoVax Labs, Inc.|edesabiotech.com - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan IBIO|CARM (carismatx.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan XTLB (XTL Biopharmaceuticals, Ltd.)|Utang jangka cendhak perusahaan Bolt Biotherapeutics Inc. BOLT|HCWB - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan APVO (Aptevo Therapeutics)|AIM ImmunoTech Inc. (AIM) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Aditxt, Inc.|GRI (GRI Bio Corp) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan XORTX Corp|Kewajiban jangka cendhak perusahaan REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan SCNI (Scinai Immunotherapeutics Ltd.)|Gunggunge utang jangka cendhak CalciMedica Inc (CALI)|AFMD - Utang jangka cendhak perusahaan|Allakos Inc. (ALLK) - Kewajiban jangka cendhak perusahaan|hookipapharma.com (HOOK) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan IGM Biosciences|Kewajiban jangka cendhak perusahaan ITOS|Utang jangka cendhak perusahaan Ocean Biomedical Inc|Utang jangka cendhak perusahaan TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Tanggungan utang jangka cendhak perusahaan